InsidersTradesSigma
Track the 펩트론 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 펩트론 has logged 2 public disclosures. Market capitalisation: €3,144.8bn. The latest transaction was reported on 10 March 2026 (Purchase). Among the most active insiders: 삼성자산운용. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Peptron is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and pharmaceutical technologies.